| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-102 |
| PharmacoGx | KIN001-102 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FLT3 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | CAV1 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | RCOR1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | NUCKS1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | FHL2 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | SBK1 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | ZNF606 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | CCND3 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | CBFA2T3 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | CD7 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-07 |
